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ABSTRACT 
Aceclofenac  was  microencapsulated  using  rosin  by  o/w  emulsion  solvent  evaporation 
technique.  The  effect  of  three  formulation  variables  including  the  drug:polymer  ratio, 
emulsifier (polyvinyl alcohol) concentration and organic solvent (dichloromethane) volume 
were  examined.    The  prepared  batches  were  characterized  for  microspheres  particle  size 
distribution, encapsulation efficiency and in vitro release behavior.  The study reveals that 
drug:polymer ratio had a considerable effect on the entrapment efficiency, however particle 
size distribution of microspheres was more dependent on the volume of dichloromethane and 
polyvinyl  alcohol  concentration  rather  than  on  the  drug:  polymer  ratio.  Drug,  polymer 
concentrations were varied to obtain optimum release profile for sustaining the action of the 
drug. 
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INTRODUCTION 
          Conventional oral drug administration does not usually provide rate-controlled release 
or target specificity. In many cases, conventional drug delivery provides sharp increase in 
drug concentration often achieving toxic level and following a relatively short period at the 
therapeutic level of the drug concentration eventually drops off until re-administration.  In 
order to obtain maximum therapeutic efficacy, it becomes necessary to deliver an agent to the 
target tissue in the optimal amount for the required period of time, thereby causing little 
toxicity and minimal side effects
1. Desired drug release can be provided by rate-controlling 
membranes  or  by  implanted  biodegradable  polymers  containing  dispersed  medication. 
Microparticulate  drug  delivery  systems  are  considered  and  accepted  as  a  reliable  one  to 
deliver the drug to the target site with specificity, to maintain the desired concentration at the 
site  of  interest  without  untoward  effects
2.  Microencapsulation  is  a  useful  method  which Lakshmana Prabu S et al. Formulation and evaluation of sustained release microspheres of…  52 
   
Ars Pharm, Vol. 50 nº2; 51-62. 
prolongs  the  duration  of  drug  effect  significantly  and  improves  patient  compliance. 
Eventually the total dose and few adverse reactions may be reduced since a steady plasma 
concentration is maintained
3. 
          In recent years much research in drug delivery has been focused on degradable polymer 
microspheres.  Administration  of  medication  via  such  systems  is  advantageous  because 
microspheres can be ingested or injected, can be tailored for desired release profiles and in 
some cases it can provide organ-targeted release
4,5,6,7,8. The meaning of microencapsulation is 
converting liquids to solids, altering colloidal and surface properties, providing environmental 
protection and controlling the release characteristics by using the coating materials.  
 
          Emulsion  solvent
5,  phase-separation  method
10  and  spray  drying  method
11  are 
commonly used for the preparation of microspheres.  The success of any microencapsulation 
method depends on many factors such as the drug solubility, partition co-efficiency, polymer 
composition,  molecular  weight  etc.  Among  the  various  microencapsulation  methods, 
emulsion  solvent  evaporation  technique  is  often  widely  used  to  prepare  microcapsules  of 
water insoluble drugs (within the water insoluble polymer). Microspheres are formed by the 
evaporation of an organic solvent from dispersed oil droplets containing both polymer and 
drug 
4; 7; 15; 16; 17.  
 
          Aceclofenac is a non-steroidal anti-inflammatory drug, widely used in the management 
of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Usual therapeutic dose is 
100 mg twice daily and half life is 3-4 hrs; thus it is necessary to be administered frequently 
in order to maintain the desired concentration. Therefore, aceclofenac is an ideal candidate for 
sustained release formulation, resulting in more reproducible drug absorption and reducing 
the risk of local irritations compared to single dosage forms.  
          The  aim  of  the  present  work  was  to  encapsulate  aceclofenac  with  biodegradable 
polymer rosin, the effect of different formulation variables such as concentration of drug, 
polymer,  polyvinyl  alcohol  and  solvent,  the  effect  of  these  variables  on  particle  size 
distribution, encapsulation efficiency and its in vitro release behavior.  
 
MATERIALS AND METHODS 
Materials 
          Aceclofenac was obtained as gift samples from Micro Labs, Hosur, India; Polyvinyl 
alcohol  (PVA  -  MW  1,30,000)  from  SD  fine  chemicals,  Rosin  from  Yucca  Enterprises, 
Dombivilli, Thane, India were used in the study. Dichloromethane, Potassium dihydrogen 
phosphate,  Sodium  hydroxide  and  Camphor  were  procured  from  S.D.  Fine  Chemicals, 
Mumbai, India. 
Methods 
Preparation of microspheres 
          Microspheres of Aceclofenac were prepared based on o/w emulsion solvent evaporation 
technique by using rosin as a polymer. Different batches of microspheres were prepared by 
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aqueous phase (100 ml) containing various percentages of PVA as the emulsifying agent; the 
mixture was emulsified by constant stirring at 400 rpm for 4 h by using a propeller stirrer 
(Remi, India). The dispersed drug and polymer solution was immediately transformed into 
fine  droplets,  which  subsequently  solidified  into  rigid  microspheres  due  to  the  solvent 
evaporation.  The  particles  were  collected  by  filtration,  washed  and  dried  in  vacuum 
desiccators and characterized.  
Drug-Excipients Compatibility Studies 
          Excipients are integral components of almost all pharmaceutical dosage forms thus it is 
mandatory  to  detect  any  possible  physical  or  chemical  interaction  of  the  drug  with  the 
excipients since the excipient can affect the bioavailability and stability of the drug. The drug 
and the excipients must be compatible with one another to produce a product that is stable, 
efficacious, attractive, easy to administer and safe. If the excipients are new and have not been 
used  in  formulations  containing  the  active  substance,  the  compatibility  studies  have  a 
considerable importance. DSC and FTIR techniques were commonly used to investigate the 
compatibility between the drug and the various excipients used in the formulation.  
Sample preparation and analysis by DSC 
          The samples were prepared by physical mixture of drug and excipients (1:1) using a 
clean  dried  glass  mortar  and  pestle.    Samples  (5-10  mg)  were  accurately  weighed  and 
hermetically sealed in aluminum pans.  Thermograms were obtained using Shimadzu (DSC-
60) instrument, heating at a constant rate of 10º C/min, over a temperature range of 40 – 
300ºC.  To maintain on inert atmosphere nitrogen gas was purged at a rate of 20 ml/min. 
Sample preparation and analysis by FTIR 
          FTIR spectra data was taken on a Shimadzu (FTIR-8300) instrument to find out the 
chemical  stability  of  the  drug  with  excipients.    FTIR  spectra  of  drug,  polymer  and 
composition  of  final  formulation  were  obtained  by  mixing  with  potassium  bromide  and 
converted into pellets by pressing at 1 ton/unit.  Spectral scanning was done in the range of 
4000 – 400
-1 cm. 
Percentage Yield 
          The  yield  of  microspheres  was  determined  by  comparing  the  whole  weight  of 
microspheres formed against the combined weight of the copolymer and drug.  
 
 
 
Particle size and size distribution 
          The microspheres were suspended in liquid paraffin and  examined using an optical 
microscope. Laser diffraction technique (Malvern Instruments Ltd. Malvern, UK) was used to 
study the size distribution of the microspheres. The dispersant used was cyclohexane and the 
average particle size was calculated and expressed in microns. 
Percentage yield =
      Mass of microspheres obtained            
X 100
 
             Total weight of drug and polymer used 
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Drug Content analysis 
          Ten milligram accurately weighed portion of microspheres were taken in a clean 100 
ml volumetric flask and dissolved in about 2 ml of acetone and the volume was made up to 
the  mark  with  buffer  pH  7.4.  After  filtration  and  dilution,  samples  were  analyzed 
spectrophotometrically  and  the  amounts  of  drug  encapsulated  in  the  microspheres  were 
calculated. The drug content of each sample was determined in triplicate and the results were 
averaged. The entrapment efficiency of microspheres were calculated by dividing the actual 
drug content to the theoretical drug content of microspheres.  
Morphological characterization of microspheres 
          The  surface  morphology  of  microspheres  was  investigated  using  scanning  electron 
microscopy (SEM) by mounting on stubs using double-sided adhesive tapes.  The stubs were 
then vacuum-coated with gold-palladium alloy using coat sputter JFC 1100 (JEOL, Japan) 
and the microspheres were observed and examined using SEM (JEOL JSM 6308). 
In-vitro release studies 
          In vitro release studies were carried out using USP type I apparatus at 37 ± 0.5
oC in 900 
ml of phosphate buffer solution (pH 7.4) for 24 h.  Microspheres equivalent to 20 mg drug 
was placed into the baskets (tied using muslin cloth), and rotated at 100 rpm.  A sample of 5 
ml was with drawn at various time intervals like 0.5, 1, 2, 4, 6, 8, 10, 12 and 24 h and filtered, 
analyzed by UV spectrophotometrically at 275 nm using Shimadzu 1610 spectrophotometer.   
DISCUSSION 
          The details of quantities of drug, polymer, stabilizer and solvents used are given in 
Table 1. Percentage yield of the microspheres and encapsulation efficiency were calculated 
and the results are shown in Table 2. First order spectroscopy method was used in order to 
nullify the interference effect due to polymer in the estimation of aceclofenac.  First order 
standard  plot  of  aceclofenac  was  found  to  be  linear  in  phosphate  buffer  pH  (7.4)  at 
wavelength  261.4  nm  between  the  concentrations  of  4  -  40µg/ml.    The  linear  regression 
equation  was  found  to  be  y=0.0006x-0.0001;  the  correlation  coefficient  was  found  to  be 
0.9986. The UV spectrums are shown in Figure 1 and 2. 
TABLE 1.  Composition of aceclofenac loaded microspheres 
Ingredients (mg)  F1  F2  F3  F4  F5  F6  F7 
Aceclofenac 
Rosin 
PVA (100ml) 
Dichloromethane 
Water 
Camphor 
200 
200 
0.25% 
10 ml 
100 ml 
--- 
400 
200 
0.25% 
10 ml 
100 ml 
--- 
600 
200 
0.25% 
10 ml 
100 ml 
--- 
200 
400 
0.25% 
10 ml 
100 ml 
--- 
200 
600 
0.25% 
10 ml 
100 ml 
--- 
200 
400 
0.25% 
10 ml 
100 ml 
200 
200 
600 
0.25% 
10 ml 
100 ml 
200 
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TABLE 2. Results of percentage yield and encapsulation efficiency 
Formulation   Percentage Yield (%)  Encapsulation efficiency (%) 
F1 
F2 
F3 
F4 
F5 
F6 
F7 
40.0 
46.0 
60.1 
80.0 
88.83 
85.0 
88.5 
23.1 
36.2 
53.0 
72.85 
80.24 
73.12 
78.3 
 
FIGURE 1. UV spectrum of aceclofenac and rosin (acetone with buffer pH 7.4) 
 
 
FIGURE 2. First order absorption spectra of aceclofenac and rosin (acetone with phosphate 
buffer pH 7.4) 
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Drug-Excipients Compatibility Studies 
          DSC is useful in the investigation of solid-state interactions; hence thermograms were 
generated for both pure drug and drug excipient mixtures. The DSC thermograms reveal that 
the physical mixture of aceclofenac with rosin showed superimposition of the thermograms, 
but a slight preshift was observed at 148.91 °C instead of 156.54 °C. There is no considerable 
change in the melting endotherms of both the drug and excipients as well as there is no other 
endotherm and exotherm were observed. The thermograms are shown in Figure 3.   
 
FIGURE 3.  DSC Thermograms 
 
          Aceclofenac contains one carbonyl group, one ester group and one secondary amine 
which have characteristic band values around 3276, 1770 and 3317 cm
-1. Infrared studies 
reveal that three characteristic bands around 3276, 1770 and 3317 cm
-1 were present in all 
spectra while no new bands or shift in characteristic bands were seen in the mixtures. IR 
spectra are shown in Figure 4. DSC and FTIR results revealed that there is no interaction 
between the drug and the excipients used in the formulation. 
FIGURE  4.  IR spectra of aceclofenac and mixture 
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SEM studies 
          The  scanning  electron  micrograph  of  microspheres  of  formulations  F6  and  F7  are 
shown in Figure 5 and 6. It can be seen that microspheres are almost spherical with smooth 
surface. 
FIGURE 5.  SEM of formulation F6 
 
FIGURE 6.  SEM of formulation F7 
 
 
In vitro release studies 
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formulations F4 and F5 were taken into consideration for in vitro release studies. In vitro 
release  studies  were  carried  out  in  phosphate  buffer  pH  7.4  for  a  period  of  24  h.  The 
cumulative percent release was found to be 38.90% and 22.69% for formulation F4 and F5 
respectively. The release results are shown in Figure 7. 
FIGURE 7. In vitro release of aceclofenac from F4 and F5 formulations 
In vitro release studies
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          In order to improve the release rate of drug from microspheres, 2.0 % w/v of camphor 
was included in the formulations. The composition of the formulation is shown in Table 3.  
Camphor was dissolved in the polymer solution, its forms uniform distribution in the polymer 
solution.  Upon  microencapsulation  the  particles  will  be  getting  encapsulated  by  polymer 
along with camphor. On drying due to volatile nature camphor may get evaporated and forms 
pores on the surface of the microspheres, through which drug could easily diffuse to the 
aqueous phase or dissolution medium. Microspheres were prepared by the emulsion solvent 
evaporation method and evaluated. The percentage yield was found to be between 85.0 % and 
88.5%; encapsulation efficiency was found to be 73.12% and 78.3% for formulation F6 and 
F7 respectively. In vitro release studies for the prepared microspheres were carried out by the 
above method.  The cumulative percentage release after 24 h was found to be 55.76% and 
29.83%  for  formulation  F6  and  F7  respectively.  The  release  results  are  shown  in  Fig.  8. 
Formulation F6 showed better release rate than F7. The reason for this retarded drug release 
may be due to the hydrophobic nature of the polymer, which prevents the penetration of the 
dissolution medium into the microspheres leading to slower dissolution and diffusion of the 
drug molecules from the microspheres. 
TABLE 3.  Shape and particle size of rosin loaded microspheres 
 
Formulatio
n 
Specific 
surface 
area 
(m
2/g) 
Surface 
weighed 
mean 
D[3,2] 
Volume 
weighed 
mean 
D[4,3] 
Mean 
particle 
size d(0.1)   
(µm)   
Mean 
particle 
size d(0.5)  
  (µm) 
Mean 
particle 
size d(0.9)  
  (µm) 
F6 
F7 
0.68 
0.472 
8.826 
12.708 
23.331 
37.392 
6.906 
10.651 
24.144 
36.955 
44.598 
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FIGURE 8. In vitro release of aceclofenac from F6 and F7 formulations 
In vitro release studies
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Evaluation of formulation variables 
          As mentioned previously, the effect of different formulation variables on microspheres 
properties  including  entrapment  efficiency  and  particle  size  distribution  were  evaluated.  
Variables  studied  in  this  investigation  were  as  follows.  Drug  :polymer  ratio,  volume  of 
dichloromethane and polyvinyl alcohol concentration in the external phase of the emulsion.  
 
Particle size distribution 
          Particle  size  and  shape  parameters  like  surface  weighted  mean  D  [3,  2],  volume 
weighed mean D [4.3] and specific surface area was determined. Particle size distribution 
parameters like d (0.1), d (0.5) and d (0.9) were analyzed.  When increasing the concentration 
of  wall  forming  material  the  mean  diameter  of  the  particle  also  increased  which  may  be 
attributed to the increase in viscosity of the internal phase.  The results are given in Table 3. 
Effect of drug:polymer ratio 
          The effects of drug and polymer ratio on the aceclofenac of rosin microspheres were 
studied, the results revealed that drug loading was observed maximum at drug:polymer ratio 
at  1:3.  On  the  other  hand,  there  is  not  any  significant  difference  was  observed  between 
particle size distribution of microspheres prepared with drug:polymer ratios of 1:2 and 1:3. 
 
Effect of dichloromethane volume 
           The effects of dichloromethane volume were studied. The results are shown in Table 4.  
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TABLE 4. The effect of volume of dichloromethane variables on the drug entrapment 
efficiency and particle size of rosin microspheres (drug : polymer ratio 1:2) 
Volume  of 
Dichlormethane 
(ml) 
Theoretical 
drug  loading 
(mg) 
Actual  drug 
loading (mg) 
Encapsulatio
n  efficiency 
(%) 
Mean  particle 
size d(0.5) (µm)  
9.0 
9.25 
9.5 
9.75 
10.0 
10.25 
200 
200 
200 
200 
200 
200 
145.76 
146.12 
145.42 
145.18 
146.30 
146.40 
72.88 
73.06 
72.71 
72.59 
73.15 
73.20 
23.68 
23.76 
23.91 
24.02 
24.14 
24.30 
 
The results revealed that the drug content of microspheres was not affected by the volume of 
dichloromethane, but the particle sizes were found to change significantly. This may also be 
due to the increase in the volume of dichloromethane leads to decrease in viscosity of the 
internal phase could be an effective factor in the droplet size of the emulsion in the aqueous 
medium.  In this case, it seems that the shear effect of the propeller is able to break the large 
droplets into smaller ones, which are solidified into microspheres on solvent evaporation. 
Effect of PVA concentration 
          The effect of PVA as an emulsifying agent in the external phase of the emulsion was 
investigated. The results are shown in Table 5. The amount of PVA as an emulsifying agent 
did not influence the drug loading and entrapment efficiency of microspheres however the 
particle  size  of  microspheres  is  seen  to  be  dependent  on  the  PVA  concentration  in  the 
continuous  phase.  The  results  revealed  that  on  increasing  PVA  concentration,  more  PVA 
molecules may overlay the surface of the droplets, providing an increased protection of the 
droplets against coalescence resulting in the production of small emulsion droplets. Since 
microspheres were formed from emulsion droplets after solvent evaporation, their size was 
dependent on the size of emulsion droplets.  
TABLE 5.  The effect of PVA concentration on drug entrapment and particle size of rosin 
microspheres 
Concentration of 
PVA as continuous 
phase 
Theoretical 
drug  loading 
(mg) 
Actual  drug 
loading (mg) 
Encapsulatio
n  efficiency 
(%) 
Mean  particle 
size d(0.5) (µm)  
0.1 
0.15 
0.2 
0.25 
200 
200 
200 
200 
145.26 
145.82 
146.22 
146.48 
72.63 
72.91 
73.11 
73.24 
30.28 
28.54 
26.43 
24.14 
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CONCLUSION 
          This  study  shows  that  o/w  emulsion  solvent  evaporation  can  be  used  as  a  simple 
method  to  prepare  Aceclofenac  sustained  release  microspheres  by  suing  rosin  as  an 
encapsulating  polymer.  The  drug  entrapment  efficiency  of  prepared  microspheres  were 
affected only by the drug:polymer ratio.  The  emulsifier concentration and organic phase 
volume influenced the particle size distribution of microspheres. Based on the above findings, 
it was observed that formulation F6 showed optimum release characteristics. The release rate 
of  drug  from  the  microspheres  could  be  properly  controlled  for  about  24h.  Appropriate 
variation in the proportions of drug; polymer and stabilizer can lead to a product with the 
desired controlled release features. 
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